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Hyperlipidemia and hepatitis in 
liver-specific CREB3L3 knockout 
mice generated using a one-step 
CRISPR/Cas9 system
Yoshimi Nakagawa1,2, Fusaka Oikawa1, Seiya Mizuno3, Hiroshi Ohno1, Yuka Yagishita1, 
Aoi Satoh1, Yoshinori Osaki1, Kenta Takei1, Takuya Kikuchi1, Song-iee Han1, Takashi Matsuzaka1, 
Hitoshi Iwasaki1, Kazuto Kobayashi1, Shigeru Yatoh1, Naoya Yahagi1, Masaaki Isaka1, 
Hiroaki Suzuki1, Hirohito Sone4, Satoru Takahashi2,3,5, Nobuhiro Yamada1 & Hitoshi Shimano1,2
cAMP responsive element binding protein 3-like 3 (CREB3L3), a transcription factor expressed in the 
liver and small intestine, governs fasting-response energy homeostasis. Tissue-specific CREB3L3 
knockout mice have not been generated till date. To our knowledge, this is the first study using the 
one-step CRISPR/Cas9 system to generate CREB3L3 floxed mice and subsequently obtain liver- and 
small intestine-specific Creb3l3 knockout (LKO and IKO, respectively) mice. While LKO mice as well as 
global KO mice developed hypertriglyceridemia, LKO mice exhibited hypercholesterolemia in contrast 
to hypocholesterolemia in global KO mice. LKO mice demonstrated up-regulation of hepatic Srebf2 
and its corresponding target genes. No phenotypic differences were observed between IKO and floxed 
mice. Severe liver injury was observed in LKO mice fed a methionine-choline deficient diet, a model for 
non-alcoholic steatohepatitis. These results provide new evidence regarding the hepatic CREB3L3 role 
in plasma triglyceride metabolism and hepatic and intestinal CREB3L3 contributions to cholesterol 
metabolism.
CREB3L3 is a membrane-bound transcription factor belonging to the CREB/ATF family. Creb3l3 is expressed in 
the liver and intestine1. Translated CREB3L3 protein localizes to the endoplasmic reticulum (ER) before transfer 
to the Golgi apparatus, where the transcriptionally active N-terminal region is cleaved prior to translocation to 
the nucleus2. Creb3l3 mRNA has consistently been shown to be highly regulated by fasting and re-feeding, with 
nuclear levels of the active form of CREB3L3 seen to increase in times of starvation3. CREB3L3 and peroxisome 
proliferator activated receptor alpha (PPARα ) synergistically activate hepatic fibroblast growth factor 21 (Fgf21) 
expression and exert effects on energy metabolism through the modulation of plasma FGF21 levels4,5. Synthesized 
FGF21 proteins are secreted into the circulation and have been shown to exert effects on numerous peripheral 
tissues including the brain, white adipose tissue (WAT), brown adipose tissue (BAT), and skeletal muscle. FGF21 
activates lipolysis in WAT and thermogenesis in BAT6. Further, these effects alleviate the symptoms of diabetes 
and hyperlipidemia via reductions in plasma glucose, insulin, triglyceride (TG), and cholesterol levels. CREB3L3 
reduces plasma TG levels by increasing hepatic gene expression of apolipoproteins such as apolipoprotein A-IV 
(Apoa4), Apoa5, and Apoc21. These apolipoproteins activate plasma lipoprotein lipase (LPL) activity, resulting in 
reduced plasma TG levels.
Genetically modified mouse models represent valuable tools for the studying development and diseases. 
Traditional gene targeting in embryonic stem (ES) cells, although suitable for generating sophisticated genetic 
modifications in endogenous genes, remains complex and time-consuming. However, the production of 
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genetically modified mice and rats has been greatly accelerated by recently developed approaches using direct 
injection of DNA or mRNA encoding site-specific nucleases into one-cell-stage embryos, thereby generat-
ing DNA double-strand breaks (DSBs) at specified sequences leading to targeted mutations. Co-injection of 
single-stranded or double-stranded DNA templates homologous to sequences flanking DSB can produce mutant 
alleles with precise point mutations or DNA inserts. Engineered endonucleases, including zinc-finger nucle-
ases (ZNFs), transcription activator-like effector nucleases (TALENs), and the clustered regularly interspaced 
short palindromic repeat (CRISPR)/CRISPR associated protein 9 (Cas9) system have all demonstrated utility in 
the rapid generation of genetically modified animals. The CRISPR/Cas9 system is an RNA-mediated adaptive 
immune system found in bacteria and archaea that protects against the invasion of viruses and plasmids7. On 
the basis of locus organization and signature Cas gene composition, three major types of CRISPR systems (type 
I–III) have been identified8. The modified type II CRISPR/Cas9 system, derived from Streptococcus pyogenes, is 
widely used for gene editing8,9. The type II bacterial CRISPR/Cas9 system has been demonstrated as an efficient 
gene-targeting technology that facilitates multiplexed gene targeting. Because the binding of Cas9 is guided by 
simple base-pair complementarities between engineered single-guide RNA (sgRNA) and target genomic DNA 
sequences, it is possible to direct Cas9 to any genomic locus by providing engineered sgRNA. Previous reports 
have demonstrated that the generation of floxed mice in one step by the insertion of two loxP sites into the same 
allele of genes using the CRISPR/Cas9 system10–12. However, the generation of tissue-specific knockout (KO) mice 
by crossing floxed mice developed using the methods outlined above with tissue-specific Cre Tg mice has yet to 
reported.
Until now, CREB3L3 loss of function studies have relied on Creb3l3−/− mice. However, the contribution of 
intestinal CREB3L3 to lipid metabolism has yet to be specifically examined. Accordingly, conditional Creb3l3 
knockout mice are required to evaluate the tissue-specific functions of CREB3L3. In the present study, we gener-
ated Creb3l3 floxed mice using the one-step CRISPR/Cas9 system. For the first time, both liver-specific Creb3l3 
knockout (LKO) and intestine-specific Creb3l3 knockout (IKO) mice were successfully generated by crossing 
Creb3l3 floxed mice with albumin- and villin-promoter Cre Tg mice, respectively. Phenotypic characteristics were 
then compared between tissue-specific CREB3L3 KO mice.
Results
Generation of Creb3l3 floxed mice using a one-step CRISPR/Cas9 system. CREB3L3 is a key regu-
lator of glucose and lipid metabolism. Although Creb3l3−/− mice have previously been generated13, the generation 
of conditional Creb3l3 knockout mice has yet to be reported. Since CREB3L3 is specifically expressed in the liver 
and intestine, it is important to elucidate the differential functions of CREB3L3 in these organs. Accordingly, we 
aimed to generate Creb3l3 floxed (floxed) mice using the CRISPR/Cas9 system. Our plan was to insert flox site in 
intron 3 and 11 of the Creb3l3 gene, respectively, and then delete the about 7kbp between both sites by the Cre-
loxP system. A px330 vector was used to express gRNA for the targeted region of the gene of interest (Creb3l3 in 
the present study) and Cas9 protein in mouse zygotes14. We identified appropriate CRISPR target sites in introns 
3 and 11 of the Creb3l3 gene. Double-stranded DNAs (dsDNAs) of 20 bp were derived from regions of introns 3 
and 11 of the Creb3l3 gene and inserted into the px330 vector, with the resultant plasmids designated as px330-
Creb3l3 intron 3 and px330-Creb3l3 intron 11, respectively. We designed corresponding loxP site oligos with 250-
bp sequences homologous to each side surrounding each sgRNA-mediated DSB. To facilitate the detection of the 
intended insertions, DNA fragments targeting intron 3 were engineered to contain a BamHI restriction site and 
other oligos targeting intron 11 to contain an EcoRI site in addition to the loxP sequences, respectively (Fig. 1a 
and Supplementary Fig. 1).
The EGxxFP system15 involves the formation of a fragment of pCX-EGxxFP-Creb3l3 cleaved from the 
px330-Creb3l3 vector in order to produce full-length functional EGFP by HDR. The cleavage activity of the 
px330-Creb3l3 intron 3 and px330-Creb3l3 intron 11 vectors were confirmed using the EGxxFP system. 
Fragments of intron 3 and intron 11 of the Creb3l3 gene were inserted into the multi-cloning site of pCX-EgxxFP, 
with the resultant vectors designated pCX-EGxxFP-Creb3l3 intron 3 and pCX-EGxxFP-Creb3l3 intron 11, respec-
tively. To confirm the above mechanism, the target sequence of Creb3l3 intron 3 or 11 for pCX-EGxxFP-Creb3l3 
and px330-Creb3l3 vectors were co-transfected into HEK293T cells, respectively, and EGFP signals were observed 
in co-transfected cells. EGFP signals were clearly detected following co-transfection with both pX330 Creb3l3 and 
pCX-EGxxFP vectors (Fig. 1b). We further confirmed the ability of px330-Creb3l3 vectors to cleave both intron 3 
and intron 11 of the Creb3l3 genome, respectively.
Next, the px330-Creb3l3 intron 3 and px330-Creb3l3 intron 11 vectors, and two dsDNA fragments intron 3 
and intron 11 containing a loxP sequence, were injected into mouse 277 zygotes and 239 embryos were trans-
ferred into the oviducts of pseudopregnant recipient ICR mice with the aim of generating 20 pups (Fig. 1c). 
Genomic DNA from pups born after microinjection were amplified by PCR and subjected to digestion with 
BamHI and EcoRI separately. Genomic DNA from pups 4 and 8 (lanes 4 and 8 in Fig. 1d,e) were not detected 
by genotyping PCR for intron 3 and intron 11. This result demonstrates an important issue with the one step 
CRISPR/Cas9 system. Introns 3 and 11 of genomic Creb3l3 were predicted to be completely deleted in these mice. 
Fortunately, we identified one mouse (No. 6) which carried loxP sites at both the intron 3 and intron 11 sites of the 
same allele (Fig. 1d,e). It was confirmed that the loxP site within intron 3 was heterozygously inserted; however, 
the intron 11 site was homozygously inserted in this mouse (Fig. 1c–e).
Generation of liver- and intestine-specific Creb3l3 knockout mice. As Creb3l3 is predominantly 
expressed in the liver and small intestine2, we aimed to specifically delete Creb3l3 in these tissues. The lox 
sites were homozygously inserted in both sites of genomic Creb3l3 in the floxed mice, which were confirmed 
by sequencing (Supplementary Fig. 2). To analysis off-target cleavages, we searched candidates that matches 
12 bases at the 3′ end and the NGG PAM sequence15 with CRISPR direct (https://crispr.dbcls.jp/). Here we 
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examined 6 potential off-target sites, resulting in no mutations (Supplementary Fig. 3). To determine whether 
the px330-Creb3l3 intron 3 and px330-Creb3l3 intron 11 vectors were integrated into the chromosomes, we 
Figure 1. Strategy used for one step CRISPR/Cas9 generation of Creb3l3 floxed mice. (a) Method used to 
generate Creb3l3 floxed mice using the one-step CRISPR/Cas9 system. (b) Creb3l3 CRISPR activity was evaluated 
using the EGxxFP system. Robust EGFP signals were observed following the co-transfection of HEK293T cells 
with the pCX-EGxxFP-Creb3l3 intron vector and either the pX330 empty vector or px330-Creb3l3 intron vector. 
Scale bars represent 100 μ m. (c) Generation of mutant mice via two vectors and two DNA fragments injection. 
(d,e) Genotyping to confirm insertion of loxP sites into Creb3l3 introns 3 (d) and 11 (e). Mouse tail genomic DNA 
was isolated and subjected to genotyping PCR. PCR products were cut using BamHI or EcoRI restriction enzymes.
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performed PCR assay with mouse genomic DNA and a primer pair for Cas9 detection. Cas9 PCR products were 
not observed in the floxed mice (Supplementary Fig. 4). Generated floxed mice were then crossed with mice 
expressing tissue-specific Cre Tg mice (Fig. 2a,b). We used the albumin-promoter Cre Tg mice for the generation 
of LKO mice and the villin-promoter Cre Tg mice for IKO mice. To confirm the generation of LKO and IKO mice, 
we assessed gene and protein expression of CREB3L3 in the liver and intestine using qPCR and western blotting. 
CREB3L3 mRNA and protein were specifically deleted in the liver of LKO mice and intestine of IKO mice, respec-
tively (Fig. 2c,d). Levels of CREB3L3 mRNA and protein in the intestine of LKO mice and liver of IKO mice were 
similar to levels measured in CREB3L3 floxed mice. As a result, we obtained tissue-specific CREB3L3 knockout 
mice using a one-step injection method in markedly shorter time than reported for previous techniques. To our 
knowledge, the present study represents the first report of the use of the one-step CRISPR/Cas9 system in gener-
ating tissue-specific knockout mice. Although previous reports have demonstrated the generation of floxed mice, 
none have reported the application of this approach to the generation of knockout mice10.
Liver-specific Creb3l3 knockout mice and not intestine-specific knockout mice demonstrate 
hyperlipidemia. No significant differences in body weight or lean weight were observed between floxed, 
LKO, and IKO mice in both fasted and fed states, except an increased weight proportion attributable to fat in 
IKO mice in the fed state compared to floxed mice as estimated by DEXA scanning (Supplementary Table 1). 
Plasma TG and glucose levels have been reported to be higher, with cholesterol and FGF21 levels reported lower, 
in Creb3l3−/− mice compared to WT mice5,16. Plasma TG, cholesterol, and free fatty acid levels were significantly 
increased in LKO mice compared to floxed mice in both fasted and fed conditions (Fig. 3A,B). High-performance 
liquid chromatography (HPLC) demonstrated CM, VLDL, and LDL fractions of TG were markedly increased 
in LKO mice in both fasted and fed states (Fig. 3A). Plasma FGF21 levels were markedly decreased in LKO 
mice in the fasted state, but were unchanged in the fed state (Fig. 3B). No difference in plasma glucose levels 
were observed between LKO and floxed mice (Fig. 3C). Plasma insulin levels were increased in LKO mice in 
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Figure 2. Generation of tissue-specific Creb3l3 knockout mice. (a) Method used to generate tissue-specific 
CREB3L3 KO mice. (b) Genotyping of Creb3l3+/+ (+ /+ ), Creb3k3 f lox/+ (f/+ ), and Creb3l3flox/flox (f/f) to confirm 
insertion of loxP sites into both Creb3l3 introns 3 and 11. (c) qPCR to measure hepatic and intestinal Creb3l3 
expression in floxed, CREB3L3 LKO, and IKO mice in fasted condition (n = 5–6 per group). (d) Immunoblot 
analysis for CREB3L3 protein in hepatic and intestinal tissues from floxed, LKO, and IKO mice in fasted 
condition.
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both fasted and fed states, but not significantly in fed state (Fig. 3C). No changes in plasma parameters were 
observed in IKO mice, except for a decrease in plasma glucose in the fed condition compared to floxed mice 
(Supplementary Table 2). Histological analyses of liver sections following H&E staining, demonstrated no appar-
ent morphological differences between LKO and floxed mice (Fig. 3D). No difference in hepatic lipid content, 
including TG and cholesterol, were observed between floxed and LKO mice in both fasted and fed states, with 
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Figure 3. Plasma parameters of CREB3L3 LKO mice. (A) Plasma TG and cholesterol, and HPLC analysis 
of plasma TG and cholesterol levels (B) NEFA, and plasma FGF21 levels, and (C) glucose, and insulin levels in 
8-week-old male floxed and CREB3L3 LKO mice in fasted and fed conditions. (D) Histological analyses of liver 
sections stained with HE from 8-week-old male floxed and CREB3L3 LKO mice in fasted condition. (E) Liver 
TG and cholesterol levels in floxed and CREB3L3 LKO mice in fasted and fed conditions. (F) VLDL secretion 
analysis. Eight week-old male floxed and LKO mice were fasted for 18 h prior to the administration of Triton 
WR-1339 with blood collected at the indicated times. Plasma TG and cholesterol levels were evaluated. (G) TG 
clearance assays. Mice were fasted for 24 h prior to oral administration of olive oil with blood collected at the 
indicated time for plasma TG level measurements (n = 5–10 per group). * p < 0.05 and * * p < 0.01.
www.nature.com/scientificreports/
6Scientific RepoRts | 6:27857 | DOI: 10.1038/srep27857
no difference in liver weights observed (Fig. 3E and Supplementary Table 1). LKO mice have higher plasma cho-
lesterol levels and Creb3l3−/− mice have lower1, while IKO mice have no difference compared with control mice, 
indicating that CREB3L3 in enterohepatic circulation plays a pivotal role in cholesterol metabolism.
Liver-specific Creb3l3 knockout mice have dysfunctional TG clearance but not VLDL secretion. 
Previous reports have described lower plasma LPL activity in Creb3l3−/− mice leading to the lower TG clearance 
compared to WT mice, with no effect on VLDL secretion1. LKO mice were subjected to evaluation of VLDL secre-
tion and TG clearance. In VLDL secretion tests, no difference in plasma TG levels was observed between LKO 
and floxed mice, indicating normal VLDL secretion in LKO mice (Fig. 3F). There was a trend toward increased 
plasma cholesterol levels in LKO mice compared to floxed mice from 1 h after injection (Fig. 3F). In TG clearance 
testing, plasma TG levels were significantly higher in LKO mice compared to floxed mice (Fig. 3G). These results 
indicate that the dysregulation of TG clearance in LKO mice can be explained by hepatic Creb3l3 deficiency.
Hepatic deletion of Creb3l3 dysregulates the expression of genes related to lipid metabolism. 
Next we evaluated the expression of genes related to lipid metabolism including TG, cholesterol, and fatty acids 
in the livers of LKO mice in fasted and fed states (Fig. 4). No significant changes in gene expression levels were 
observed in the fed state. CREB3L3 is predominantly active in the fasted state, rather than the fed state. Thus, 
this result was expected. In the fasted state, expression levels of Ppara, another key regulator of fatty acid oxi-
dation, were reduced in LKO mice. Consistently, hepatic expression levels of the PPARα target gene, carnitine 
palmitoyltransferase 1a (Cpt1a), were also reduced. The expression of another target gene, acyl-Coenzyme A 
oxidase 1, palmitoyl (Acox1), were significantly increased. No differences in the expression levels of regulators 
of fatty acid synthesis, such as sterol regulatory element binding transcription factor 1a (Srebf1a) and Srebf1c, 
and their corresponding target genes, stearoyl-Coenzyme A desaturase 1 (Scd1), and ELOVL family member 
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Figure 4. Hepatic gene expression profiles in CREB3L3 LKO mice. Hepatic gene expression profiles in 8-week-
old male floxed and LKO mice in fasted and fed conditions (n = 4–7 per group). * p < 0.05 and * * p < 0.01.
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6, elongation of long chain fatty acids (yeast) (Elovl6), were observed between floxed and LKO mice in either 
nutritional state, but fatty acid synthase (Fasn) was significantly increased. On the other hand, the cholesterol 
synthesis regulator, Srebbf2, was significantly increased in the fasted state, leading to an increase in its corre-
sponding target genes including 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (Hmgcs1), 3-hydroxy-3
-methylglutaryl-Coenzyme A reductase (Hmgcr), and low density lipoprotein receptor (Ldlr). Consistent with a 
previous report in Creb3l3−/− mice16, fatty acid elongases, such as Elovl2 and Elovl5, were significantly decreased 
in LKO mice in the fasted state indicating a changed composition of fatty acids in the livers of LKO mice. Of the 
examined lipoprotein lipase (LPL) activity regulators, expression levels of activators such as Apoa4, Apoa5, and 
Apoc2 were significantly reduced, while expression levels of a suppressor, Apoc3, were conversely increased, not 
significant, in livers of LKO mice compared to floxed mice in the fasted state. These results provide evidence of the 
dysregulation of TG clearance in LKO mice, consistent with previously reported phenotypes of Creb3l3−/− mice. 
No significant differences in expression levels of bile acid metabolic genes, nuclear receptor subfamily 1, group 
H, member 4 (Fxr encoded by Nr1h4), small heterodimer partner (Shp), or cytochrome P450, family 7, subfam-
ily a, polypeptide 1 (Cyp7a1) were observed between LKO and floxed mice. In consistent with previous reports 
about Creb3l3−/− mice1,4,5,14, changes in the hepatic expression of genes related to fatty acid oxidation, fatty acid 
elongation, and apolipoprotein in LKO mice were same as Creb3l3−/− mice. LKO mice especially exhibited the 
increased hepatic expression of genes related to cholesterol synthesis. Given these changes in gene expression, we 
suggest the increased hepatic cholesterol synthesis and reductions in plasma LPL activity observed in LKO mice 
contribute to hyperlipidemia.
Deficiency of Creb3l3 in the liver accelerates non-alcoholic steatohepatitis. To determine the 
effects of hepatic CREB3L3 on NASH pathology, LKO mice were fed the methionine-choline deficient (MCD) 
diet for 4 weeks leading to the induction of non-alcoholic fatty liver disease (NAFLD). Plasma alanine ami-
notransferase (ALT) and aspartate aminotransferase (AST) levels were acutely and significantly increased in 
LKO mice fed an MCD diet, indicating severe and acute liver injury (Fig. 5a). Histological analysis of sections 
stained with H&E demonstrated disrupted hepatic architecture in LKO mice, with Masson’s trichrome (MT) 
staining demonstrating greater induction of fibrosis in LKO mice compared to floxed mice (Fig. 5b). Surprisingly, 
no differences in hepatic TG and cholesterol contents were observed between floxed and LKO mice (Fig. 5c). 
Consistent with the results of the MT staining analysis, hepatic gene expression studies demonstrated signifi-
cantly increased hepatic expression of fibrosis-related genes such as transforming growth factor, beta 1 (Tgfb1), 
actin, alpha 2, smooth muscle, aorta (Acta2), and collagen, type I, alpha 1 (Col1a1) in LKO mice (Fig. 5c). There 
was a trend toward decreased hepatic expression of the CREB3L3 target gene, In FGF21 KO mice fed the MCD 
diet, non-alcoholic steatohepatitis (NASH) phenotypes were induced17. Fgf21 was decreased in LKO mice, 
thereby in part contributing to the pathology of NASH. There was a trend toward increased expression levels of 
inflammatory mediators including Il6, Il1b, and Ccl2; however, these differences were not statistically significant. 
Interestingly, no significant differences were observed in the expression levels of fatty acid and cholesterol syn-
thesis regulator genes, such as Srebf1c and Srebf2, between LKO and floxed mice (Fig. 5c). These results indicate 
hepatic Creb3l3 deficiency acutely exacerbates MCD diet-induced liver injury and fibrosis, without abnormal 
hepatic lipid accumulation.
Discussion
There are three previous studies reporting the generation of conditional mutant mice by introduction of two flox 
sites using the CRISPR/Cas9 system10–12. However, no reported studies have used the one-step CRISPR/Cas9 
system to generate floxed mice and subsequently tissue-specific knockout mice. The present study is the first to 
report the generation of tissue-specific knockout mice and to analyze the function of the gene of interest in mice. 
We generated Creb3l3 floxed mice by direct microinjection of 2 vectors and 2 DNA fragments into C57BL/6J 
zygotes using the CRISPR/Cas9 system. Creb3l3 is predominantly expressed in the liver and small intestine. We 
intended to generate liver-specific and intestine-specific Creb3l3 knockout mice by crossing Creb3l3 floxed mice 
with tissue-specific promoter-driven Cre Tg mice, respectively. In contrast to Creb3l3−/− mice reported to have 
high plasma TG levels only1, LKO mice demonstrated higher plasma TG and cholesterol levels but not hepatic 
steatosis in the fasting condition. These changes were considered to be attributable to intestinal expression of 
Creb3l3 in addition to hepatic expression. Collectively, we propose that CREB3L3 functions as a mediator of lipid 
metabolism via regulation of the enterohepatic circulation.
Previous reports have demonstrated the generation of floxed mice using the one-step CRISPR/Cas9 system; 
however, no studies have demonstrated the generation of tissue specific knockout mice10. The major limitation of 
the one step system is that in situations where 2 sites at the same allele are ligated, the genomic portion between 
2 sites could be deleted leading to failed insertion of the loxP sites. Furthermore, the frequency of the insertion 
of 2 loxP sites into the same allele may be extremely low. We obtained only one line of Creb3l3 floxed mice with 2 
loxP sites within the same allele.
We generated both LKO and IKO mice through breeding with mice generated using the one step CRISPR/
Cas9 system. IKO mice had no apparent differences in metabolic parameters compared to floxed mice, while 
LKO mice demonstrated hyperlipidemia. These findings indicate hepatic CREB3L3 contributes to cholesterol 
and TG homeostasis. Consistent with previous reports, hepatic expression of LPL activator genes was reduced 
and suppressor genes was increased in LKO mice, underlying the observed increases in plasma TG levels in LKO 
mice. Hepatic de novo cholesterol synthesis was apparently activated leading to increased plasma cholesterol 
levels in LKO mice. Accordingly, hepatic expression levels of genes related to cholesterol synthesis were higher in 
LKO mice compared to floxed mice. Despite the higher plasma cholesterol levels in LKO mice, no differences in 
hepatic cholesterol content were observed between floxed and LKO mice. Expression levels of Srebf2 are known 
to be regulated by a feedback loop between gene expression and cholesterol levels. Therefore, increased expression 
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of Srebf2 and its corresponding target genes led to up-regulation of de novo cholesterol synthesis in LKO mice, 
resulting in increased plasma cholesterol levels. SREBP-2, a regulator of the expression of genes involved in cho-
lesterol synthesis, is similar to CREB3L3 as both molecules have a transmembrane domain cleaved by site-1 and 
site-2 proteases. We hypothesized that CREB3L3 and SREBP-2 compete as targets of these cleavage enzymes, 
the detailed mechanism of which is described in a manuscript currently under submission (Nakagawa Y, paper 
in preparation). In addition, FGF21 suppresses Srebf2 expression in the liver of Apoe−/− mice18. Plasma FGF21 
levels were lower in LKO mice, but not IKO mice than floxed mice. The results of the present study indicate 
liver-specific deletion of CREB3L3 leads to activation of Srebf2 expression and the SREBP cleavage process result-
ing in the stimulation of SREBP-2 protein activity. These changes were shown in only LKO mice, not Creb3l3−/− 
mice, thereby supporting that the function of CREB3L3 in enterohepatic circulation contributes to the regulation 
of hepatic SREBP2 activation.
We hypothesized that lipid metabolism dysregulation in LKO mice influences the pathogenesis of NAFLD in 
response to the MCD diet. Surprisingly, LKO mice demonstrated increased liver injury and fibrosis in the absence 
of the excess hepatic lipid accumulation compared to floxed mice, indicating liver-specific deletion of Creb3l3 
accelerates the development of non-alcoholic steatohepatitis. MCD diet-fed Fgf21−/− mice also exhibit NASH 
phenotypes17, thereby supporting that a decrease of Fgf21 in LKO contributes to same phenotypes. In addition, 
we are aware of data demonstrating increased inflammation and infiltration of macrophages in Creb3l3−/− mice 
fed the MCD diet along with liver injury and fibrosis (Nakagawa Y, unpublished data). NAFLD patients, and in 
particular patients with NASH, are more likely to exhibit increased intestinal permeability compared with healthy 
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Figure 5. Hepatic Creb3l3 deficiency aggravates MCD diet-induced liver injury and fibrosis. Eight-week-
old male mice were fed the MCD diet for 4 weeks. (a) Plasma AST and ALT levels during feeding on MCD diet. 
(b) Hepatic histological analysis (HE staining, and MT staining) and hepatic lipid contents in floxed and LKO 
mice fed the MCD diet for 4 weeks. (c) Hepatic gene expression profiles of floxed and LKO mice fed the MCD 
diet for 4 weeks (n = 5–10 per group). * p < 0.05 and * * p < 0.01.
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controls19. Likewise, MCD-fed mice develop intestinal permeability changes after an initial phase of liver injury19. 
NASH is associated with increased intestinal permeability suggesting the early phase of liver injury and inflam-
mation contributes to injury to the intestinal barrier, thereby indicating the contribution of gut–liver crosstalk 
in NASH pathogenesis20. Taken together, these results indicate enhanced disease progression in Creb3l3−/− mice 
is due to aberrant inflammation in mice with intestine-specific deletion of CREB3L3 in addition to mice with 
liver-specific deletion of CREB3L3. According, CREB3L3 may contribute to the pathogenesis of metabolic syn-
drome through its role in regulating enterohepatic circulation. However, further studies are required to verify the 
intestinal function of CREB3L3 in models of metabolic disease such as those fed the MCD diet.
The present study demonstrated the utility of the one-step CRISPR/Cas9 system as a simple and less 
time-consuming method for generating genetically modified mouse models. The findings of the present study 
further demonstrate a crucial role for CREB3L3 in the pathogenesis of NAFLD through its function in regulat-
ing enterohepatic circulation. Future studies using intestine-specific Creb3l3 knockout mice may demonstrate 
CREB3L3 as a therapeutic target for improving hyperlipidemia.
Experimental procedures
Animals. This project was approved and performed in accordance with the guidelines of the Animal Care 
Committee of the University of Tsukuba. Creb3l3tm1.1Sad/J (Creb3l3−/−)13, B6.Cg-Tg (Alb-cre) 21Mgn/J (Albumin 
Cre Tg)21, and B6.Cg-Tg (Vil1-cre) 1000Gum/J (Villin Cre Tg) mice were purchased from Jackson Laboratory. 
For the NAFLD study, eight-week-old male mice were fed the MCD diet (Oriental Yeast, Tokyo, Japan) for 4 
weeks. Fat and lean mass analyses were performed using dual-energy X-ray absorptiometry (DEXA) with a 
PIXImus mouse densitometer (GE Medical Systems Lunar). All animal husbandry procedures and animal exper-
iments were consistent with the University of Tsukuba’s Regulation of Animal Experiment and were approved by 
the Animal Experiment Committee, University of Tsukuba.
Vector construction. The px330 vector (Addgene plasmid 42230) was a gift from Dr. Feng Zhang14. 
Creb3l3 intron 3 CRISPR F (5′-caccGTGTATGTGTGCCATAGCACAGG-3′) and Creb3l3 intron 
3 CRISPR R (5 ′-aaacCCTGTGCTATGGCACACATACAC-3 ′) ,  Creb3l3  intron 11 CRISPR F 
(5′-caccGATACCAGGGGTGATGGTGCAGG-3′) and Creb3l3 intron 11 CRISPR R (5′-aaacCCTGCACCA 
TCACCCCTGGTATC-3′) oligo DNAs were annealed using standard methods. Annealed DNA was purified by eth-
anol precipitation. Short double-stranded DNA fragments were inserted into the BbsI restriction site of the px330 
vector. Constructed plasmids were designated px330-Creb3l3 intron 3 and px330-Creb3l3 intron 11, respectively. 
For the EGxxFP system15, regions of intron 3 and intron 11 of the Creb3l3 gene were amplified using standard PCR 
methods using the following primers: Creb3l3 intron 3-EGxxFP-F: 5′-GATATCACACTGAGTTCACATAG-3′, 
Creb3l3 intron 3-EGxxFP-R: 5′-GATATCAAACAGGAGGTCAAGGAC -3′, Creb3l3 intron 11-EGxxFP-F: 
5 ′-GATATCTAAAAAAAT T TAGATAAAAGAAAAAG-3 ′ ,  and Creb3l3  intron 11-EGxxFP-R: 
5′-GATATCTGGGACTTAAACTCCAGTTCTCGGC-3′. PCR products were inserted into the pCX-EGxxFP 
plasmid. Constructed plasmids were designated pCX-EGxxFP-Creb3l3 intron 3 and pCX-EGxxFP-Creb3l3 intron 
11, respectively.
Transfection. The px330 and pCX-EGxxFP vectors were co-transfected into HEK293T cells using X-treme 
9 (Roche).
Microinjection. Female C57BL/6J mice were injected with pregnant mare serum gonadotropin (PMSG) and 
human chorionic gonadotropin (hCG) at 48-h intervals and mated with male C57BL/6J mice. Fertilized one-cell 
embryos were collected from oviducts. Then, 5 ng/μ l of px330 vector (circular) and 10 ng/μ l dsDNA donors were 
injected into the pronuclei of one-cell-stage embryos according to standard protocols (Gordon and Ruddle 1981). 
Injected one-cell embryos were then transferred into pseudopregnant ICR mice.
Genotyping for Creb3l3 conditional knockout mice. Genomic DNA was obtained from tail clip-
pings and PCR was performed using EX Taq (Takara Bio) and the following primers: Typing Creb3l3 intron 3 F: 
5′-ATCACACTGAGTTCACATAG-3′, Typing Creb3l3 intron 3 R: 5′-TAAGCAGATGTGTGAGGGTTACAG-3′, 
Typing Creb3l3 intron 11 F: 5′-AGGGGCAGGACAGTGGTCTGCTATG-3′, Typing Creb3l3 intron 11 R: 
5′-ATCTACTCTCTGAGCCATCCGCCTCAAG-3′. Amplified DNA fragments of Creb3l3 intron 3 and intron 
11 were cut using BamHI and EcoRI, respectively, and subjected to electrophoresis on an agarose gel.
Off-target analysis. Potential off-target sites were found using CRISPR target with rules outlined previ-
ously15. Thirteen bases proceeding the PAM sequence with NGG were aligned with mouse genome. The genome 
fragments containing the off-target were sequenced.
Detection of Cas9 DNA. Genomic DNA was obtained from tail clippings and PCR was performed 
using EX Taq (Takara Bio) and the following primers: Cas9 F: 5′-AGTTCATCAAGCCCATCCTG-3′, Cas9 R: 
5′-GAAGTTTTCTGTTGGCGAAGC-3′. Amplified DNA fragments of Cas9 were subjected to electrophoresis 
on an agarose gel.
Determination of metabolic parameters. Plasma glucose, TG, cholesterol, NEFA, AST, and ALT con-
centrations were measured using Wako enzymatic kits. Plasma insulin was measured using mouse insulin ELISA 
Kits (Sibayagi). Plasma FGF21 concentrations were measured using a mouse/rat FGF21 Quantikine ELISA assay 
(R&D Systems). Hepatic TG and cholesterol levels were measured using previously described protocols22.
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High-performance Liquid Chromatography Analysis. For lipoprotein distribution analyses, pooled 
plasma samples from 4 to 5 mice per group were analyzed using an upgraded high-performance liquid chroma-
tography (HPLC) technique as previously described (Skylight Biotech)23.
Histological analysis. Harvested livers were fixed, embedded in paraffin, sectioned, and stained with hema-
toxylin and eosin (HE) or Masson’s trichrome (MT).
Immunoblotting. Total cell lysates from mouse livers were prepared as previously described22, separated 
by SDS-PAGE, and subjected to Western blot analysis using anti-CREB3L35, α -Tubulin (05-829, Millipore), and 
β -Actin (sc-47778 Santa Cruz) antibodies.
TG Production assay. Mice were fasted for 24 h prior to injection with Triton WR-1339 (0.5 mg/g body 
weight, Sigma-Aldrich) via the tail vein to block the clearance of nascent ApoB-containing lipoproteins. Blood 
samples were collected at 0, 30, 60, and 120 min after Triton injection23.
Postprandial TG Response assay. Mice were fasted for 16 h prior to the oral administration of 200 μ l olive 
oil1. Blood samples were collected at 0, 3, 6, and 9 h after olive oil administration.
Analysis of gene expression. Total RNA from cells and tissues was prepared using Trizol reagent 
(Invitrogen). Templates for real-time PCR analysis were prepared by cDNA synthesis (Invitrogen) using total 
RNA. Real-time PCR was performed using the ABI Prism 7300 System (ABI) and SYBR Green Master Mix 
(Roche)24. Primer sequences are listed in Supplementary Table 3.
Statistical analyses. Statistical significance was determined using unpaired Student’s t-tests. Differences 
with P < 0.05 were considered significant. Data are expressed as the mean ± SEM.
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